ArticleBritish journal of cancer2018

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.

R D Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.